Screener
Eligibility screening
A Study Comparing Chemotherapy to CPX-351 and/or Gilteritinib for Acute Myeloid Leukemia
185 US sites in AL, AR, AZ, CA +43
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.